Ed Kaye was the chief medical officer of Sarepta Therapeutics for nearly six years before being thrust into the spotlight. In April 2015, CEO Chris Garabedian resigned, and Kaye took up the job of trying to notch the first-ever approval... Read more »
Next up in my ongoing series of offbeat chats with local tech execs and investors is Jennifer Lum.
Lum is a leader in Boston’s mobile advertising sector, having co-founded or held a key position in three such startups—m-Qube (acquired by... Read more »
To judge the first 100 days of a new administration is, as many pundits have pointed out, an odd vestige of history, more convenient than significant. Which is why we’ll start this week’s roundup with our 99-day evaluation of the Trump... Read more »
Amazon, the behemoth of digital and physical commerce, started out as an independent bookseller, albeit an online one, based in a home in Bellevue, WA. Now that it’s doing everything else—this week it deployed artificial intelligence to judge your fashion choices... Read more »
TCC Software Solutions, an Indianapolis-based IT cloud-hosting company, announced this week that it has acquired two businesses: Vertex Solutions Group and Triple Impact. Financial terms of the deal were not disclosed.
Jim Pangallo, principal partner at TCC, says the two... Read more »
What would happen if a total stranger with a poor command of English asked the payroll manager of an American corporation to send him the Internal Revenue Service Form W-2’s for the company’s entire staff?
Answer: Some payroll managers would obligingly... Read more »
BioMarin Pharmaceuticals has won the first FDA approval for a treatment for Batten disease, a rare group of disorders that rob children of vision, cognitive abilities, and motor skills, and usually prove deadly before adulthood.
The San Rafael, CA-based biotech’s cerliponase... Read more »
San Antonio — Academic research centers are perennially seeking new ways to get more work commercialized, from offices that are tasked with spotting marketable science to workshops meant to help scientists learn to think like entrepreneurs.
But the problem may be... Read more »
Richardson, TX—The University of Texas at Dallas today formally kicks off its Blackstone LaunchPad program, one of three cross-disciplinary entrepreneurship centers opening at universities across the state.
The program, funded by a $1 million donation from the charitable arm of... Read more »
Scott Gottlieb’s nomination to the top post of the FDA is on its way to the full U.S. Senate.
The Senate Health, Education, Labor & Pensions Committee voted 14-9 on Thursday to approve Gottlieb’s nomination to become FDA commissioner. All of... Read more »
[Updated 4/27/17 5:29 pm. See below.] A year ago, Exact Sciences’s stock was in a slump, languishing below $10 per share. But since then, its stock price has climbed back to more than $20 per share.
That rally continued... Read more »
Two of the most noteworthy drugs to win FDA approval over the past year, eteplirsen (Exondys 51) and nusinersen (Spinraza), have something important in common: Patient groups have played a critical role in both of their stories.
Eteplirsen, Sarepta Therapeutics’ (NASDAQ:... Read more »
Paul Allen has pledged $30 million to help house homeless families in Seattle, as the city grapples with an ongoing crisis and debates how to pay for it.
With an additional $5 million in capital from city coffers, the funding from... Read more »